| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |